Clinical trial · Observational
Sexual Behavior in Oropharyngeal Patients Versus Head and Neck Cancer Patients, With or Without HPV Infection
NCT00508170CI-TRIAL-00007596completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Primary Objectives: 1. To determine whether high-risk sexual behaviors are more common in patients with oropharyngeal cancer than in patients with head and neck cancers of other sub-sites. 2. To determine if high-risk sexual behaviors are more common in patients with HPV (human papillomavirus) associated head and neck cancer than those without evidence of HPV-16 infection.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Head and Neck Cancer | Malignant Head and Neck Neoplasm | ALIAS | 0.90 |
| Human Papillomavirus Infection | — | UNRESOLVED | — |
| Oropharyngeal Cancer | Malignant Oropharyngeal Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Questionnaire | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Patients with Oropharyngeal Cancer
- interventionNames
- Behavioral: Questionnaire
- label
- Patients with Non-Oropharyngeal Cancer
- interventionNames
- Behavioral: Questionnaire
Primary outcomes (1)
- measure
- Number of Responders with High-risk Sexual Behaviors
- timeFrame
- 1 month for mailing and return of questionnaires
- description
- Written self-administered questionnaire responses analyzed to determine whether patients with oropharyngeal cancer have history of high-risk sexual behavior (defined as 15 or more lifetime sexual partners) greater than that of patients with tumors of other sites of head and neck
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Patients with diagnosed squamous cell carcinoma of the head and neck that participated in the molecular epidemiology study LAB00-062 of head and neck cancer between 1995 and 2005. 2. Head and Neck cancer participants of LAB00-062 that are still alive. 3. Head and Neck cancer participants of LAB00-062 that have known mailing addresses in the U.S.A. 4. Patients must be 18 years and older. 5. Patients will have completed their primary treatment but may be undergoing treatment for a second primary or recurrent disease. 6. Ability to read, write, and speak Spanish or English. Exclusion Criteria: n/a
References
Publications (0)
Data not yet available
No reference posted for this study.